Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.74 |
| ▸ | NAAA | Q02083 | 1/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.68 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.61 |
| ▸ | FAAH | O00519 | 5/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.57 |
| ▸ | CNR1 | P21554 | 2/20 | 0.57 |
| ▸ | CNR2 | P34972 | 2/20 | 0.57 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | PPARD | Q03181 | 1/20 | 0.56 |
| ▸ | PPARA | Q07869 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL94472 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL8337296 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL10420519 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL8356691 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL93996 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL10422182 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL10686810 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL10767322 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL30678823 | 0.98 | CASP2 (0.71) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL30835571 | 0.98 | CASP2 (0.71) | CASP2NAAAEPHX2PLA2G2AFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012093031-A1 | METHOD FOR CROSSLINKING MOISTURE CROSSLINKABLE POLYMERS COMPRISING A WATER DONOR SYSTEM | WACKER CHEMIE AG (DE) | 2012-07-12 | — | — | WO | disclosed |
| US-7868135-B2 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | BIOWEST THERAPEUTICS INC. (CA) | 2011-01-11 | — | — | US | disclosed |
| EP-2147925-A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | MIGENIX INC. (CA) | 2010-01-27 | — | — | EP | disclosed |
| EP-1656390-A2 | COMPOSITIONS OF LIPOPEPTIDE ANTIBIOTIC DERIVATIVES AND METHODS OF USE THEREOF | MIGENIX INC. (CA) | 2006-05-17 | — | — | EP | disclosed |
| EP-1226113-B1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | FIRMENICH & CIE (CH) | 2005-11-09 | — | — | EP | disclosed |
| US-20050153876-A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | MIGENIX INC. (CA) | 2005-07-14 | — | — | US | disclosed |
| WO-2005000878-A2 | COMPOSITIONS OF LIPOPEPTIDE ANTIBIOTIC DERIVATIVES AND METHODS OF USE THEREOF | MIGENIX INC. (CA) | 2005-01-06 | — | — | WO | disclosed |
| US-6677297-B2 | PERFUMES FOR TEXTILES; PROLONGED DIFFUSION | FIRMENICH SA (CH) | 2004-01-13 | — | — | US | disclosed |
| US-20020144360-A1 | Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors | FIRMENICH SA (CH) | 2002-10-10 | — | — | US | disclosed |
| EP-1226113-A1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | Firmenich S.A. (CH) | 2002-07-31 | — | — | EP | disclosed |
| WO-2001028980-A1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | FIRMENICH S.A. (CH) | 2001-04-26 | — | — | WO | disclosed |
| EP-0382548-B1 | Thermoplastic resin composition | SUMITOMO CHEMICAL CO (JP) | 1994-06-29 | — | — | EP | disclosed |
| US-5116906-A | Molding materials | SUMITOMO CHEMICAL CO., LTD. (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0382548-A2 | Thermoplastic resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-08-16 | — | — | EP | disclosed |
| US-4921942-A | Organometallic compounds | STEPAN COMPANY (US) | 1990-05-01 | — | — | US | disclosed |
| US-4724174-A | AMIDO CARBOXYL SOAPS; FILM-FORMING; SUBSTANTIVITY | STEPAN COMPANY (US) | 1988-02-09 | — | — | US | disclosed |
| US-4675422-A | ALUMINUM COATINGS | STEPAN COMPANY (US) | 1987-06-23 | — | — | US | disclosed |
| EP-0220934-A2 | Aluminium carboxylates | STEPAN COMPANY (US) | 1987-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050153876-A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | NRDC, NOD2, NGLY1 | CASP2 827/4885NAAA 345/4885EPHX2 3716/4885 |
| US-20020144360-A1 | Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors | ADH1C, ADH1A, CBR1 | CASP2 722/4885NAAA 2383/4885EPHX2 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.